These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26798212)

  • 21. Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association-National Cancer Center 2022 Criteria.
    Yoon JK; Han DH; Lee S; Choi JY; Choi GH; Kim DY; Kim MJ
    Cancer Res Treat; 2023 Jul; 55(3):939-947. PubMed ID: 36791769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic criteria for hepatocellular carcinoma ⩽3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging.
    Choi SH; Byun JH; Lim YS; Yu E; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
    J Hepatol; 2016 May; 64(5):1099-1107. PubMed ID: 26820629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy.
    Sersté T; Barrau V; Ozenne V; Vullierme MP; Bedossa P; Farges O; Valla DC; Vilgrain V; Paradis V; Degos F
    Hepatology; 2012 Mar; 55(3):800-6. PubMed ID: 22006503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases.
    Piana G; Trinquart L; Meskine N; Barrau V; Beers BV; Vilgrain V
    J Hepatol; 2011 Jul; 55(1):126-32. PubMed ID: 21145857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines.
    Golfieri R; Garzillo G; Ascanio S; Renzulli M
    Dig Dis; 2014; 32(6):696-704. PubMed ID: 25376286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis.
    Lin MT; Wang CC; Cheng YF; Eng HL; Yen YH; Tsai MC; Tseng PL; Chang KC; Wu CK; Hu TH
    PLoS One; 2016; 11(11):e0166157. PubMed ID: 27829060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Performance of 2018 KLCA-NCC Practice Guideline for Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced MRI in Patients with Chronic Hepatitis B or Cirrhosis: Comparison with LI-RADS Version 2018.
    Lee SM; Lee JM; Ahn SJ; Kang HJ; Yang HK; Yoon JH
    Korean J Radiol; 2021 Jul; 22(7):1066-1076. PubMed ID: 33739633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
    Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
    Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Practice guidelines for management of hepatocellular carcinoma 2009].
    Korean Liver Cancer Study Group and National Cancer Center, Korea
    Korean J Hepatol; 2009 Sep; 15(3):391-423. PubMed ID: 19783891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria.
    Leoni S; Piscaglia F; Golfieri R; Camaggi V; Vidili G; Pini P; Bolondi L
    Am J Gastroenterol; 2010 Mar; 105(3):599-609. PubMed ID: 19935786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic algorithm for subcentimeter hepatocellular carcinoma using alpha-fetoprotein and imaging features on gadoxetic acid-enhanced MRI.
    Huang P; Wu F; Hou K; Zhou C; Xiao Y; Wang C; Miao G; Yang C; Zeng M
    Eur Radiol; 2024 Apr; 34(4):2271-2282. PubMed ID: 37792079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
    Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
    J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.
    ;
    Gut Liver; 2019 May; 13(3):227-299. PubMed ID: 31060120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout?
    Joo I; Lee JM; Lee DH; Jeon JH; Han JK; Choi BI
    Eur Radiol; 2015 Oct; 25(10):2859-68. PubMed ID: 25773941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of the American Association for the Study of Liver Disease and Barcelona criteria for the diagnosis of hepatocellular carcinoma.
    Pahwa A; Beckett K; Channual S; Tan N; Lu DS; Raman SS
    Abdom Imaging; 2014 Aug; 39(4):753-60. PubMed ID: 24699935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study.
    Granito A; Galassi M; Piscaglia F; Romanini L; Lucidi V; Renzulli M; Borghi A; Grazioli L; Golfieri R; Bolondi L
    Aliment Pharmacol Ther; 2013 Feb; 37(3):355-63. PubMed ID: 23199022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosing Borderline Hepatic Nodules in Hepatocarcinogenesis: Imaging Performance.
    Choi BI; Lee JM; Kim TK; Dioguardi Burgio M; Vilgrain V
    AJR Am J Roentgenol; 2015 Jul; 205(1):10-21. PubMed ID: 26102378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm.
    Renzulli M; Biselli M; Brocchi S; Granito A; Vasuri F; Tovoli F; Sessagesimi E; Piscaglia F; D'Errico A; Bolondi L; Golfieri R
    Gut; 2018 Sep; 67(9):1674-1682. PubMed ID: 29437912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.
    Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea
    Korean J Radiol; 2022 Dec; 23(12):1126-1240. PubMed ID: 36447411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.